24
Views
2
CrossRef citations to date
0
Altmetric
Miscellaneous

N-substituted quinuclidinol esters as potential therapeutic antimuscarinic agents

Pages 377-380 | Published online: 02 Mar 2005

Bibliography

  • BROWN JH, TAYLOR P: Muscarinic receptor agonists and antagonists. In: The Pharmacological Basic of Therapeutics. Hardman JG, Limbird LE (Eds), McGraw Hill, New York (2001):155–173.
  • EGLEN PM, HEGDE SS WATSON N: Muscarinic receptor subtypes and smooth muscle function. Pharmacol Rev (1996) 48(4):531–565.
  • ••Describes the role of muscarinic receptors inperipheral smooth muscle.
  • EHLERT FJ, THOMAS EA, GERSTIN EH, GRIFFIN MT: Muscarinic receptors and gastrointestinal smooth muscle. In: Muscarinic Receptor Subtypes M Smooth Muscle. Eglen RIVI (Ed.), CRC Press, Boca Raton (1997):92–147.
  • ••Describes the role of muscarinic recptors in gastrointestinal smooth muscle and glands.
  • EHLERT FJ: Pharmacological analysis of the contractile role of M2 and M3 muscarinic receptor in smooth muscle. In: Receptors and Channels. Kenakin T (Ed.), Harwood Academic Publishers (In Press).
  • •Describes the use of muscarinic antagonists to identify the contractile role of M2 and M3 receptors in various peripheral smooth musdes.
  • EHLERT FJ, SAWYER GW, ESQUEDA EE: Contractile role of M2 and M3 muscarinic receptors in gastrointestinal smooth muscle. Life Sci. (1999) 64(6–7):387-394 (Published erratum appears in Life ScL (1999) 64(26):2535).
  • CARMINE AA, BROGDEN RN: Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases. Drugs (1985) 30:85–126.
  • HULME EC, BIRDSALL NJ BUCKLEY NJ: Muscarinic receptor subtypes. Ann. Rev Pharmacol Toxkol. (1990) 30:633–673.
  • EGLEN PM: Muscarinic receptor subtypes in smooth muscle. CRC Press, Boca Raton (1997).
  • ••This book describes the contractile role of muscarinic receptors in various smooth muscle tissues.
  • EHLERT FJ, OSTROM RS, SAWYER GW:Subtypes of the muscarinic receptor in smooth muscle. Life Sci. (1997) 61 (18):1729–1740.
  • •Describes the ionic mechanisms of M2 and M3 muscarinic receptors in peripheral smooth muscle.
  • MATSUI M, MOTOMURA D, KARASAWA H et al.: Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc. Nat] Acad. Sci. USA(2000) 97(17):9579–9584.
  • STENGEL PW, YAMADA M, WESS J, COHEN ML: M(3)-receptor knockout mice: muscarinic receptor function in atria, stomach fundus, urinary bladder, and trachea. Am. Physiol Regul Integc Comp. Physiol (2002) 282(5):R1443–R1449.
  • STENGEL PW, GOMEZA J, WESS J, COHEN ML: M(2) and M(4) receptor knockout mice: muscarinic receptor function in cardiac and smooth muscle in vitro. Pharmacol Exp. The]: (2000) 292 (3):877–885.
  • MATSUI M, MOTOMURA D, FUJIKAWA T et al.: Mice lacking M2 and M3 muscarinic acetylcholine receptors are devoid of cholinergic smooth muscle contractions but still viable. I NeuroscL(2002) 22:10627–10632.
  • NEWGREEN DT NAYLOR A: Comparisonof the functional muscarinic receptor selectivity of darifenacin with tolterodine and oxybutynin. Br. Pharmacol (1996) 117:107P
  • UNDEM BJ, LITCHTENSTEIN LM: Drugs used in the treatment of asthma. In: The Pharmacological Basis of Therapeutics. Hardman JG, Limbird LE (Eds), McGraw Hill, New York (2001):733–754.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.